Have a personal or library account? Click to login
Assessment of Biological Parameters that (Influence) Affect the Quality of Life in a Group of Patients with Metabolic Syndrome Cover

Assessment of Biological Parameters that (Influence) Affect the Quality of Life in a Group of Patients with Metabolic Syndrome

Acta Medica Transilvanica
Volume 26 (2021): Issue 3 (September 2021)
By: Ovidiu Boitor,  Laura Ștef,  Gabriela Boţa and  Romeo Mihăilă  
Open Access
|Nov 2021

References

  1. 1. Zhijun Tan, Ying Liang, Siming Liu, Wenjun Cao, Haibo Tu, Lingxia Guo, and Yongyong Xu. Health-Related Quality of Life as Measured with EQ-5D among Populations wit hand without Specific Chronic Conditions: A Population-Based Survey in Shaanxi Province, ChinaPLoS One. 2013;8(7):e65958. Published online 2013 Jul 2. doi: 10.1371/journal.pone.0065958 PMCID: PMC3699581.10.1371/journal.pone.0065958369958123843948
    Search in Google ScholarBack to article
  2. 2. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Greiner W, Gusi N, Herdman M, Jelsma J, Kind P, Scalone L, Ravens-Sieberer U. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875-86. doi: 10.1007/s11136-010-9648-y. PMID: 20405245; PMCID: PMC2892611.10.1007/s11136-010-9648-y289261120405245
    Search in Google ScholarBack to article
  3. 3. EuroQol Research Foundation. EQ-5D-Y User Guide, Version 2.0, 2020. Available from: https://euroqol.org/publications/user-guides/. Accessed on 12.05.2021.
    Search in Google ScholarBack to article
  4. 4. https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/ Accessed on 07.06.2021.
    Search in Google ScholarBack to article
  5. 5. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. PMID: 23184421; PMCID: PMC3764313.10.1007/s11136-012-0322-4376431323184421
    Search in Google ScholarBack to article
  6. 6. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708-15. doi: 10.1016/j.jval.2012.02.008. PMID: 22867780.10.1016/j.jval.2012.02.00822867780
    Search in Google ScholarBack to article
  7. 7. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi:10.1186/1477-7525-8-13. PMID: 20109189; PMCID: PMC2824714.10.1186/1477-7525-8-13282471420109189
    Search in Google ScholarBack to article
  8. 8. Batóg P, Rencz F, Péntek M, Gulácsi L, Filipiak KJ, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Golicki D. EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature. Kardiol Pol. 2018;76(5):860-870. doi: 10.5603/KP.a2018.0033. PMID: 29350378.10.5603/KP.a2018.003329350378
    Search in Google ScholarBack to article
  9. 9. Golicki D, Dudzińska M, Zwolak A, Tarach JS. Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire, Adv Clin Exp Med, doi: 10.17219/acem/38137.10.17219/acem/3813725923098
    Search in Google ScholarBack to article
  10. 10. Bulamu NB, Kaambwa B, Ratcliffe J. A systematic review of instruments for measuring outcomes in economic evaluation within aged care. Health Qual Life Outcomes. 2015 Nov;13:179. DOI: 10.1186/s12955-015-0372-8. PMID: 26553129; PMCID: PMC4640110.10.1186/s12955-015-0372-8464011026553129
    Search in Google ScholarBack to article
  11. 11. Yang Y, Brazier J, Longworth L. EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ. 2015;16(9):927-939. doi:10.1007/s10198-014-0638-9. PMID: 25358263; PMCID: PMC4646948.10.1007/s10198-014-0638-9464694825358263
    Search in Google ScholarBack to article
  12. 12. Schwenkglenks M, Matter-Walstra K. Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-219. doi:10.1586/14737167.2016.1146594. PMID: 26808097.10.1586/14737167.2016.114659426808097
    Search in Google ScholarBack to article
  13. 13. Shim J, Hamilton DF. Comparative responsiveness of the PROMIS-10 Global Health and EQ-5D questionnaires in patients undergoing total knee arthroplasty. Bone Joint J. 2019;101-B(7):832-837. doi:10.1302/0301-620X.101B7.BJJ-2018-1543.R1. PMID: 31256677; PMCID: PMC6616061.10.1302/0301-620X.101B7.BJJ-2018-1543.R1661606131256677
    Search in Google ScholarBack to article
  14. 14. Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective based on EQ-5D. Dordrecht (NL): Springer; 2014. DOI: 10.1007/978-94-007-7596-1. PMID: 29787044.10.1007/978-94-007-7596-129787044
    Search in Google ScholarBack to article
  15. 15. Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707-19. doi: 10.1007/s11136-015-1108-2. PMID: 26303761; PMCID: PMC4759213.10.1007/s11136-015-1108-2475921326303761
    Search in Google ScholarBack to article
  16. 16. Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS: The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28:395-413.10.1111/j.1464-5491.2010.03136.x21392061
    Search in Google ScholarBack to article
  17. 17. eq5d: Methods for Analysing EQ-5D Data and Calculating EQ-5D Index Scores https://rdrr.io/cran/eq5d/
    Search in Google ScholarBack to article
  18. 18. Hayes AJ, Clarke PM, Glasziou PG, Simes RJ, Drury PL, Keech AC: Can self-rated health scores be used for risk prediction in patients with type 2 diabetes? Diabetes Care. 2008;31:795-797.10.2337/dc07-139118184900
    Search in Google ScholarBack to article
  19. 19. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.Health Econ. 2005;14:217-230.10.1002/hec.91015386666
    Search in Google ScholarBack to article
  20. 20. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D(UKPDS 62). Med Decis Making. 2002;22:340-349.10.1177/027298902400448902
    Search in Google ScholarBack to article
  21. 21. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health. 2000;3:47-51.10.1046/j.1524-4733.2000.36028.x16464209
    Search in Google ScholarBack to article
  22. 22. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458-463.10.2337/diacare.25.3.45811874930
    Search in Google ScholarBack to article
  23. 23. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes. 2010;8:18.10.1186/1477-7525-8-18282953120132542
    Search in Google ScholarBack to article
  24. 24. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, et al. Health-related Quality of Life in Type 2 Diabetes (T2ARDIS-2). Value in Health 3. 2000;S47–S51.10.1046/j.1524-4733.2000.36028.x16464209
    Search in Google ScholarBack to article
  25. 25. Lee WJ, Song KH, Noh JH, Choi YJ, Jo MW. (2012) Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes. Journal of Korean Medical Science. 2012;27:255-260.10.3346/jkms.2012.27.3.255328677122379335
    Search in Google ScholarBack to article
  26. 26. Redekop WK, Rutten G, Koopmanschap MA, Wolffenbuttel BHR, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458-463.10.2337/diacare.25.3.45811874930
    Search in Google ScholarBack to article
  27. 27. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999;22:448-452.10.2337/diacare.22.3.44810097927
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/amtsb-2021-0042 | Journal eISSN: 2285-7079 | Journal ISSN: 2285-7079
Journal RSS Feed
Language: English
Page range: 18 - 23
Submitted on: Aug 10, 2021
|
Accepted on: Sep 2, 2021
|
Published on: Nov 3, 2021
Published by: Lucian Blaga University of Sibiu
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
health-related quality of life,
metabolic syndrome,
diabetes type 2
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2021 Ovidiu Boitor, Laura Ștef, Gabriela Boţa, Romeo Mihăilă, published by Lucian Blaga University of Sibiu
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 26 (2021): Issue 3 (September 2021)Next article